ACN
56
4
L
68
3
AIG
50
2
AES
44
3
KEY
43
-3
WDC
60
-3
MLM
54
-4
VNO
65
-3
TMO
51
3
COST
63
-3
WY
64
4
JWN
46
-14
STX
52
-3
A
39
2
ITW
64
-4
IP
67
-3
TRIP
52
3
GE
68
-4
FOX
50
2
NVDA
52
-2
ACN
56
4
L
68
3
AIG
50
2
AES
44
3
KEY
43
-3
WDC
60
-3
MLM
54
-4
VNO
65
-3
TMO
51
3
COST
63
-3
WY
64
4
JWN
46
-14
STX
52
-3
A
39
2
ITW
64
-4
IP
67
-3
TRIP
52
3
GE
68
-4
FOX
50
2
NVDA
52
-2
Financhill
Back

NYLI MacKay Muni Intermediate ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
73

MMIT
NYLI MacKay Muni Intermediate ETF

Last Price:
24.39
Seasonality Move:
0.33%
Buy
60

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Buy
73
NYLI MacKay Muni Intermediate ETF (MMIT) is a Buy

Is NYLI MacKay Muni Intermediate ETF a Buy, Sell or Hold?

  • The current NYLI MacKay Muni Intermediate ETF [MMIT] share price is $24.43. The Score for MMIT is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • MMIT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $137.94. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MMIT Stock Price Chart

What is NYLI MacKay Muni Intermediate ETF's stock price today?

  • The NYLI MacKay Muni Intermediate ETF share price today is $24.43
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MMIT is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $137.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

MMIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 61.39 Buy
Chaikin Money Flow: 53080 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.16 - 24.32) Buy
Bollinger Bands (100): (24.25 - 24.49) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 69.97 Buy
Chaikin Money Flow: 2429824 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.69) Buy
Bollinger Bands (100): (119.21 - 142.01) Buy

MMIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.32 Buy
20-day SMA: 24.24 Buy
50-day SMA: 24.35 Buy
200-day SMA: 24.3 Buy
8-day EMA: 24.33 Buy
20-day EMA: 24.29 Buy
50-day EMA: 24.32 Buy
200-day EMA: 24.3 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.25 Buy
20-day SMA: 117.78 Buy
50-day SMA: 122.17 Buy
200-day SMA: 130.04 Buy
8-day EMA: 121.1 Buy
20-day EMA: 119.12 Buy
50-day EMA: 122.54 Buy
200-day EMA: 126.1 Buy

NYLI MacKay Muni Intermediate ETF Earnings Growth & MMIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

NYLI MacKay Muni Intermediate ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):